On November 4, the U.S. Supreme Court granted Amgen’s petition to review the “enablement requirement” of Section 112 of the Patent Act. See generally Amgen Inc., v. Sanofi, No. 21-757.
Avoiding § 101 Eligibility Issues in Internet-Centric Method Claims - In Weisner v. Google LLC, Appeal No. 21-2228, the Federal Circuit held that the specific.
NATURE SIMULATION SYSTEMS INC. v. AUTODESK, INC. - Before: Newman, Lourie, and Dyk. Appeal from the Northern District of California. - Summary: “Unanswered.
In Niazi Licensing Corp. v. St. Jude Med. S.C., Inc., No. 21-1864 (Fed. Cir. Apr. 11, 2022), the Court of Appeals for the Federal Circuit ("Federal Circuit") reversed the district court's holding that the claim terms.
Nature Simulation Systems Inc. v. Autodesk, Inc., Appeal No. 2020-2257 (Fed. Cir. Jan. 27, 2022) - In its only precedential patent decision this week, the Court of.